Publication: The level of phosphorylated Akt
predominantly reflects the expressive
status of CerbB2 in invasive breast cancer
| dc.contributor.author | Chi, Yingkai | |
| dc.contributor.author | Zhao, Jing | |
| dc.contributor.author | Cui, Su-Ping | |
| dc.contributor.author | Jiang, Ping | |
| dc.contributor.author | Wang, Jian-ping | |
| dc.contributor.author | Zhang, Hong | |
| dc.contributor.author | Mao, Jing-Zhuo | |
| dc.contributor.author | Liu, Hai-Jing Liu | |
| dc.contributor.author | Hou, Lin | |
| dc.contributor.author | Zhang, Bo | |
| dc.date.accessioned | 2018-05-11T15:43:01Z | |
| dc.date.available | 2018-05-11T15:43:01Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | Although some evidence has been documented on EGFR/PI3K mediation of Akt activation in breast cancers, ILK and DNA-PK have not been investigated so far. The aim of this study was to analyze the expression of phosphorylated Akt (pAkt) in breast cancer, with respect to its upstream regulators. The immunostaining of pAkt (Ser473) in 70 invasive breast cancers revealed that status of CerbB2 could play a major role in Akt phosphorylation, while ILK was also involved in the stimulated level of pAkt. The results would provide an important clue for the activation of Akt and potential targeted therapy in breast cancer. | es |
| dc.format | application/pdf | es |
| dc.format.extent | 7 | es |
| dc.identifier.citation | Histology and histopathology, Vol. 28, n.º 5 (2013) | |
| dc.identifier.issn | 0213-3911 | |
| dc.identifier.issn | 1699-5848 | |
| dc.identifier.uri | http://hdl.handle.net/10201/58339 | |
| dc.language | eng | es |
| dc.publisher | F. Hernández y Juan F. Madrid. Universidad de Murcia. Departamento de Biología Celular e Histología | es |
| dc.rights | info:eu-repo/semantics/openAccess | es |
| dc.subject | pAkt | es |
| dc.subject | CerbB2 | es |
| dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología | es |
| dc.title | The level of phosphorylated Akt predominantly reflects the expressive status of CerbB2 in invasive breast cancer | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
Sin licencia Creative Commons.